Schizophrenia; Psychosis Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about Schizophrenia; Psychosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 3

A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia

Cognitive ImpairmentSchizophrenia; Psychosis
European Group for Research In Schizophrenia171 enrolled16 locationsNCT07084831
Recruiting
Not Applicable

Outcomes From Remediation and Behavioural Intervention Techniques

SchizophreniaPsychotic DisordersPsychosis+1 more
University of Toronto360 enrolled2 locationsNCT05731414
Recruiting
Not Applicable

Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) in Auditory Verbal Hallucinations

Schizophrenia; Psychosis
University Hospital, Caen120 enrolled1 locationNCT05550155
Recruiting

Uppsala Psychosis Cohort

Schizophrenia; Psychosis
Uppsala University120 enrolled1 locationNCT05763966
Recruiting
Not Applicable

Brain Circuitry Therapeutics for Schizophrenia

Schizophrenia; Psychosis
Indrit Begue70 enrolled2 locationsNCT06341517
Recruiting
Phase 3

Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

SchizophreniaApathySchizophrenia; Psychosis
Louisiana State University Health Sciences Center Shreveport80 enrolled1 locationNCT06482554
Recruiting
Not Applicable

Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use

Cognitive DysfunctionPsychotic DisordersCannabis Use+5 more
Douglas Mental Health University Institute134 enrolled1 locationNCT05445180
Recruiting
Not Applicable

Hjernegym - Effects of Exergaming in Psychosis: a Clinical Intervention Study

Cognitive ImpairmentSchizophrenia; Psychosis
Sykehuset i Vestfold HF48 enrolled1 locationNCT05858255